12
Participants
Start Date
October 25, 2018
Primary Completion Date
April 22, 2019
Study Completion Date
November 27, 2019
UroLift
"The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH).~During the procedure, an implant is delivered into the prostatic lobe obstructing the urethra and restricting urine flow. The distal end of the device is used to compress the lobe then the implant is delivered to retain the lobe in position, thereby increasing the urethral opening and reducing the fluid obstruction through the prostatic urethra."
Midtown Urology Associates, Austin
NeoTract, Inc.
INDUSTRY